Ann: Presentation: Phase 2 study of SNT-5505 in myelofibrosis, page-52

  1. 33 Posts.
    sorry I'm not well versed in how pharma acquisitions play out. can someone explain the potential pros and cons for proceeding to stage 3 trials self funded ($50m US cost), and partnering.

    what does the share price do in both scenarios. not looking for price predictions, more timelines and potential cost differential as a round numbered multiplier based on success
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
5.8¢
Change
0.000(0.00%)
Mkt cap ! $94.24M
Open High Low Value Volume
0.0¢ 0.0¢ 0.0¢ $0 0

Buyers (Bids)

No. Vol. Price($)
6 12205 5.9¢
 

Sellers (Offers)

Price($) Vol. No.
5.7¢ 39375 3
View Market Depth
Last trade - 09.50am 18/06/2025 (20 minute delay) ?
SNT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.